NASDAQ · Biotechnology

Foghorn Therapeutics Inc. (FHTX) Stock

$1.99 -4.78% NASDAQ: FHTX Healthcare

Valuation

MetricValue
Price$1.99
Market Cap$116.84M
P/E Ratio-2.11
P/B Ratio-1.82
P/S Ratio3.34
EPS (TTM)$-1.18
52-Week High$7.61
52-Week Low$1.79
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE72.64%
ROA-31.75%
ROCE-44.81%
Gross Margin-264.52%
Operating Margin-264.52%
Net Margin-175.78%
Debt/Equity-0.53
Current Ratio2.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$19.0M$34.0M$23.0M$31.0M
Operating Profit$-101.0M$-117.0M$-108.0M$-103.0M$-82.0M
Net Profit$-101.0M$-109.0M$-98.0M$-87.0M$-74.0M
EPS$-2.78$-2.62$-2.34$-1.58$-1.18
Op Margin-7637.1%-609.2%-315.9%-454.3%-265.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$520.0M$405.0M$286.0M$284.0M$198.0M
Total Liabilities$423.0M$405.0M$363.0M$330.0M$307.0M
Cash$101.0M$52.0M$80.0M$55.0M$81.0M
Borrowings$58.0M$52.0M$45.0M$37.0M$41.0M

Latest News

Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains? Zacks · Jul 3, 2026 Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 GlobeNewswire · Jun 5, 2026 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May GlobeNewswire · May 12, 2026 The Foghorn Therapeutics Inc. (NASDAQ:FHTX) First-Quarter Results Are Out And Analysts Have Published New Forecasts Simply Wall St. · May 11, 2026 CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-50.0M$194.0M$-118.0M$-100.0M$-86.0M
Investing Cash Flow$33.0M$-246.0M$143.0M$-31.0M$112.0M
Financing Cash Flow$1.0M$0$2.0M$2.0M$0
Net Cash Flow$8.0M$-49.0M$28.0M$-25.0M$27.0M
Free Cash Flow$-54.0M$192.0M$-119.0M$-101.0M$-86.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA-1.56
FCF Yield-69.55%
Quick Ratio3.36
Interest Coverage0.00
Return 1Y-21.64%
Return 3Y-38.55%
Return 5Y-43.01%

Ownership

Insiders Held14.30%
Institutions Held76.58%
Institutions Float Held89.35%
Institutional HolderSharesReport Date
Flagship Pioneering LLC12,674,1202026-03-31
FMR, LLC6,047,1982026-03-31
BVF Inc.5,842,0002026-03-31
Deerfield Management Company, L.P4,394,3672026-03-31
Raymond James Financial, Inc.2,602,3822026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARCTArcturus Therapeutics Holdings Inc. $12.87 +0.82% -3.91 $365.80M 0.00%
ASMBAssembly Biosciences, Inc. $22.82 -0.57% 40.98 $452.23M 0.00%
ENTAEnanta Pharmaceuticals, Inc. $12.10 -2.18% -5.32 $351.85M 0.00%
HUMAHumacyte, Inc. $0.45 -5.34% -1.00 $75.11M 0.00%
IMRXImmuneering Corporation $3.74 -3.11% -3.91 $135.77M 0.00%

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc. is led by CEO Adrian H. Gottschalk, employs 112 people, headquartered in US, publicly traded since 2020.

Foghorn Therapeutics Inc. (FHTX) stock trades at $1.99 with a market capitalization of $116.84M. The stock is valued at a price-to-earnings (P/E) ratio of -2.11, price-to-book of -1.82, price-to-sales of 3.34. Over the past 52 weeks the stock has ranged between $1.79 and $7.61, and currently trades 73.9% below its 52-week high.

On profitability, Foghorn Therapeutics Inc. generates a return on equity (ROE) of 72.64% — well above the market average, a sign of a high-quality business, return on capital employed of -44.81%, an operating margin of -264.52%, a net profit margin of -175.78%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides